Struggling with the Microsoft Edge BitLocker recovery loop error? Discover simple, step-by-step fixes to escape the endless ...

Struggling with the Windows 11 TPM attestation not supported error? Discover proven fixes to bypass TPM 2.0 requirements and ...

It’s officially a deal spree for Solve Industrial Motion. The engineered bearings and power transmission products distributor announced Oct. 27 the acquisition of Miller Bearing Company — a conveyor ...

To find your BitLocker recovery key, visit aka.ms/myrecoverykey using a different device, sign in with your Microsoft account, and check for the key listed under your device information. This site ...

Microsoft is giving BitLocker in Windows 11 a serious upgrade, and this time the focus is on speed and stronger key protection rather than just “more encryption.” If you have ever worried about ...

For Windows' BitLocker drive encryption, performance has been a long-standing pain point, especially as high-speed NVMe drives have become more dominant in the market. Fortunately, Microsoft has taken ...

Microsoft is rolling out hardware-accelerated BitLocker in Windows 11 to address growing performance and security concerns by leveraging the capabilities of system-on-a-chip and CPU. BitLocker is the ...

It seems obvious in retrospect, but thanks to the performance gains in modern SSDs, Microsoft has started rolling out hardware-accelerated BitLocker capabilities in Windows 11 and Windows Server 2025.

Solve Intelligence, the AI platform for the $200B+ patent industry, has raised $40M in Series B funding and is launching a new product for generating patent claim charts. Solve’s Series B comes just ...

The next generation of BitLocker, Microsoft’s encryption feature in Windows, will require next-generation Windows devices that are built on unannounced chips. “Hardware acceleration of BitLock ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...